← Back to Clinical Trials
Recruiting NCT04987957

NCT04987957 Effect Of Musıc Therapy On Anxıety Levels In COVID-19 Pandemıc

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04987957
Status Recruiting
Phase
Sponsor Abant Izzet Baysal University
Condition Anxiety
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2021-12-08
Primary Completion 2026-01-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Music Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2021-12-08 with a primary completion date of 2026-01-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study, which has a randomized controlled experimental design, was planned to determine the effect of music therapy on the anxiety level of family health personnel working in primary health care centers during the COVID-19 pandemic. The study will be carried out between 4 August and 31 December with nurses, midwives and other family health personnel working in family health centers. Participants will be randomized into two groups, a control and an intervention group. Individuals in the intervention group will receive 15 minutes of music therapy once a day for 5 days. No intervention will be made in the control group. Data Descriptive Question and State-Trait Anxiety Inventory online design; It will be collected on the Google Forms platform.. Data analysis will be done using SPSS 20 program.

Eligibility Criteria

Inclusion Criteria: * Not having a verbal or auditory communication barrier, * To voluntarily agree to participate in the research, * Not having a diagnosis of neuropsychiatric disease, * Having the opportunity to fill out the surveys online, * Possess the title of midwife or nurse. Exclusion Criteria: * Having a diagnosed neuropsychiatric disorder, * Verbal and auditory communication disability, * Not being willing to participate in the research, * Having a title other than a midwife or nurse.

Contact & Investigator

Central Contact

Sinem Kurtoğlu

✉ sinem.nehirrr@gmail.com

📞 05544657304

Principal Investigator

Saadet Can Çiçek

STUDY DIRECTOR

http://www.ibu.edu.tr/tr

Frequently Asked Questions

Who can join the NCT04987957 clinical trial?

This trial is open to participants of all sexes, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04987957 currently recruiting?

Yes, NCT04987957 is actively recruiting participants. Contact the research team at sinem.nehirrr@gmail.com for enrollment information.

Where is the NCT04987957 trial being conducted?

This trial is being conducted at Bolu, Turkey (Türkiye).

Who is sponsoring the NCT04987957 clinical trial?

NCT04987957 is sponsored by Abant Izzet Baysal University. The principal investigator is Saadet Can Çiçek at http://www.ibu.edu.tr/tr. The trial plans to enroll 42 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology